MSME (Udyam registered) Ministry of MSME
- Category
- Small (2021-22)
- Udyam number
- UDYAM-TS-20-0001603
Vani Pharma Labs Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2020
₹52.6 Cr
▲ 40% YoY
Net profit · FY 2020
₹3.37 Cr
Net margin 6.4%
EBITDA · FY 2020
₹5.94 Cr
EBITDA margin 11.3%
Authorised capital
₹4.4 Cr
Registered with MCA
Paid-up capital
₹2.65 Cr
Issued & subscribed
Open charges
₹48.8 Cr
Satisfied ₹15.34 Cr
Company age
50 yrs
Est. 1976
Directors on board
3
As per MCA filings
About Vani Pharma Labs Limited
Data last updated:
Vani Pharma Labs Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 15 June 1976 and has been in existence for over 50 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG1976PLC002040. Its GSTIN is 36AAACV8155C1ZE (Telangana). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹4.4 Cr and a paid-up capital of ₹2.65 Cr. It was formerly known as Vani Chemicals & Intermediates Limited and Vani Chemicals & Intermediates P Ltd. It is led by directors including Chakradhar Mallampati (Managing Director) and Kalyan Gadde.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Plot No. 11 Industrial Development Area Ida Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2020, the company reported a revenue of ₹52.6 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹3.37 Cr (net margin 6.4%) and EBITDA of ₹5.94 Cr (EBITDA margin 11.3%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 13% over five years.
The company is associated with 1 brand: Vani Pharma. As per MCA filings, the company has open charges of ₹48.8 Cr and satisfied charges of ₹15.34 Cr on record. Court records list 14 cases involving the company, including 2 filed by the company and 12 filed against it; 2 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹2.65 Cr; the latest was in March 2019. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Amri India Private Limited with revenue of ₹53.35 Cr.
Vani Pharma Labs Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0001603). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vanigroup.com.
Company details
CIN U24110TG1976PLC002040
Registration Number 002040
Incorporation Date 15 June 1976
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0001603
Name history
Vani Pharma Labs has undergone 3 name changes throughout its history. The company was previously known as Vani Chemicals & Intermediates Limited, Vani Chemicals & Intermediates P Ltd, and Vani Chemicals & Intermediates Ltd. The current legal name is Vani Pharma Labs Limited.
| Company Name | Status |
|---|---|
| Vani Pharma Labs Limited | Current |
| Vani Chemicals & Intermediates Limited | Previous |
| Vani Chemicals & Intermediates P Ltd | Previous |
| Vani Chemicals & Intermediates Ltd | Previous |
CIN history
Vani Pharma Labs has one previous CIN (Corporate Identification Number): U24110AP1976PLC002040. The current CIN is U24110TG1976PLC002040, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1976PLC002040 | Current |
| U24110AP1976PLC002040 | Previous |
Key People
Chakradhar Mallampati Managing Director Kalyan Gadde Director Lakshmi Kranthi Mallampati Additional Director Recognitions & Rankings of Vani Pharma Labs
Contact details
Vani Pharma Labs Limited's registered office is in Hyderabad, Telangana. Its website is vanigroup.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot No. 11 Industrial Development Area Ida Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryPharma, API Manufacturers
To see the full contact details of Vani Pharma Labs Limited, buy the company report.
Comprehensive company report
Vani Pharma Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vani Pharma Labs operates one associated brand: Vani Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of Active Pharmaceutical Ingredients, bulk drugs, and chemical intermediates in India. | vanigroup.com |
Business activity
The main business activity of Vani Pharma Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vani Pharma Labs Limited, buy the company report.
Financials of Vani Pharma Labs Limited
FY 2020 filings availableVani Pharma Labs Limited reported revenue of ₹52.6 Cr (up 40% YoY) for FY 2020.
Revenue · FY 2020
₹52.6 Cr ▲ 40%
Net profit · FY 2020
₹3.37 Cr margin 6.4%
EBITDA · FY 2020
₹5.94 Cr margin 11.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 47%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 130%
5 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 40% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹52.6 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.3% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vani Pharma Labs Limited, buy the company report.
Board of directors of Vani Pharma Labs Limited
Vani Pharma Labs has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chakradhar Mallampati Also directs: Vani Organics Private Limited | Managing Director | 22 Dec 1998 | 27 Years 10 Months | Current |
| Kalyan Gadde | Director | 22 Dec 2017 | 8 Years 10 Months | Current |
| Lakshmi Kranthi Mallampati | Additional Director | 24 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Vani Pharma Labs Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amri India Private Limited | ₹53.35 Cr (FY 2017) | 90.0% | Mumbai, Maharashtra, India | |||
| Halcyon Labs Private Limited | ₹52.86 Cr (FY 2024) | -4.0% | Mumbai, Maharashtra, India | |||
| Flax Laboratories Private Limited | ₹52.86 Cr (FY 2025) | 26.0% | Mahad, Maharashtra, India | |||
| Vani Pharma Labs Limitedthis company | ₹52.6 Cr (FY 2020) | ₹3.37 Cr | 6.4% | 40.0% | Hyderabad, Telangana, India | |
| Om Biomedic Private Limited | ₹52.57 Cr (FY 2024) | -6.0% | Hisar, Haryana, India | |||
| Ambe Phytoextracts Private Limited | ₹52.25 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Unilab Chemicals and Pharmaceuticals Private Limited | ₹51.94 Cr (FY 2024) | 5.0% | Mumbai, Maharashtra, India | |||
| Vincit Labs Private Limited | ₹51.7 Cr (FY 2025) | -12.0% | New Delhi, Delhi, India | |||
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Vani Pharma Labs Limited, buy the company report.
Auditor
Vani Pharma Labs Limited is audited by K P & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K P & ASSOCIATES | FY 2020 | 012191S |
Shareholding
The shareholding of Vani Pharma Labs Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vani Pharma Labs Limited, buy the company report.
Charges & borrowings
Open charges
₹48.8 Cr
Satisfied charges
₹15.34 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2022 | 100581050 | Standard Chartered Bank | ₹5 Cr | Open | |
| 11 May 2022 | 100579224 | Axis Bank Limited | ₹7.5 Cr | Open | |
| 12 Nov 2020 | 100389650 | Others | ₹2.52 Cr | Open | |
| 26 Jun 2020 | 100358673 | Others | ₹19.26 Cr | Open | |
| 23 Nov 2018 | 100221992 | State Bank of India | ₹14.5 Cr | Open |
To see the full charge records of Vani Pharma Labs Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Vani Pharma Labs Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹2.65 Cr; the latest was in March 2019.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹2.65 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Sep 2015 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Vani Organics Private Limited |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: Vani Organics Private Limited , 3 individuals Seller: 4 individuals |
| Jan 2006 | Funding round | ₹2.65 Cr | Investors: Vani Organics Private Limited , 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vani Pharma Labs Limited has 14 court cases on record: 2 filed by Vani Pharma Labs, 12 filed against it. 2 cases are pending and 12 are disposed.
Total cases
14
Filed by the company
2
Filed against the company
12
Pending
2
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 8 | 2 |
| High courts | 5 | 4 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Kajay Remedies Pvt Ltd Through Ajay Saboo | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Kajay Remedies Pvt Ltd Through Ajay Saboo | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Takhatsinh Shankerbhai Gohil Prop.Of Shakti Ammonia Supply Co., | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Takhatsinh Shankerbhai Gohil Prop.Of Shakti Ammonia Supply Co., | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ms. Mala Impes Pharma | Disposed |
To see the full case history of Vani Pharma Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vani Pharma Labs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vani Pharma Labs has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACV8155C1ZE | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vani Pharma Labs Limited, buy the company report.
Recent activity
Vani Pharma Labs Limited has 14 board changes on record since 1998: 3 appointments and 11 cessations. The latest: Sreehari Kumar Annamraju ceased to be Additional Director on 04 Oct 2023.
Ceased
Sreehari Kumar Annamraju ceased to be Additional Director.
Ceased
Venkata Radh Krishna Kishore Annamraju ceased to be Additional Director.
Charges
A charge with Standard Chartered Bank amounted to Rs. 5.00 Cr with Charge ID 100581050 was registered on 09 Jun 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 7.50 Cr with Charge ID 100579224 was registered on 11 May 2022.
Appointed
Lakshmi Kranthi Mallampati was appointed as Additional Director.
Ceased
Prakash Yalavarthi ceased to be Director.
Charges
A charge with Others of Rs. 19.26 Cr registered on 26 Jun 2020 with Charge ID 100358673 was modified on 29 Apr 2021.
AGM
Vani Pharma Labs Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2.52 Cr with Charge ID 100389650 was registered on 12 Nov 2020.
Charges
A charge with Others amounted to Rs. 19.26 Cr with Charge ID 100358673 was registered on 26 Jun 2020.
Filing
Vani Pharma Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Charges
A charge registered on 09 Feb 2007 via Charge ID 10046969 with Axis Bank Limited was fully satisfied on 13 Dec 2018.
25 earlier events are in the company report.
Frequently asked questions
Vani Pharma Labs is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 15 June 1976 (50+ years old) and is registered under CIN U24110TG1976PLC002040.
Vani Pharma Labs has 3 current directors:
- Chakradhar Mallampati - Managing Director
- Kalyan Gadde - Director
- Lakshmi Kranthi Mallampati - Additional Director
The latest financial statements of Vani Pharma Labs on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Vani Pharma Labs is 36AAACV8155C1ZE, registered in Telangana. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Vani Pharma Labs is U24110TG1976PLC002040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vani Pharma Labs has 14 court cases on record: 2 filed by the company and 12 filed against it. 2 are pending. Most are in the district courts.
Vani Pharma Labs was incorporated on 15 June 1976, making it 50+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vani Pharma Labs has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹2.65 Cr; the latest was in March 2019.
The peers of Vani Pharma Labs by revenue are Amri India Private Limited, Halcyon Labs Private Limited, Flax Laboratories Private Limited, Om Biomedic Private Limited, Ambe Phytoextracts Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sreehari Kumar Annamraju ceased to be Additional Director on 04 Oct 2023. Venkata Radh Krishna Kishore Annamraju ceased to be Additional Director on 04 Oct 2023. Lakshmi Kranthi Mallampati was appointed as Additional Director on 24 Dec 2021. Vani Pharma Labs has 14 board changes on record in total.
Yes, Vani Pharma Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0001603).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages